Article Details
Retrieved on: 2022-03-17 07:28:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Narender Dev Mantena, head, global strategy and CEO of specialty generic injectables and synthetic biology, BE pointed out that they plan to test ...
Article found on: www.business-standard.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here